$114 Million is the total value of JW Asset Management, LLC's 12 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $58,933,000 | -13.7% | 3,116,485 | +0.4% | 51.84% | +41.3% |
| AMZN | AMAZON COM INC | $32,205,000 | -8.3% | 18,552 | 0.0% | 28.33% | +50.1% | |
| HZNP | HORIZON THERAPEUTICS PUB LTD | $7,373,000 | +13.2% | 270,775 | 0.0% | 6.49% | +85.3% | |
| MSFT | MICROSOFT CORP | $5,770,000 | +3.8% | 41,500 | 0.0% | 5.08% | +69.9% | |
| PETQ | PETIQ INC | $4,058,000 | -17.3% | 148,855 | 0.0% | 3.57% | +35.4% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,849,000 | +44.0% | 444,439 | 0.0% | 1.63% | +135.8% | |
| SNDL | New | SUNDIAL GROWERS INC | $1,459,000 | – | 304,334 | +100.0% | 1.28% | – |
| OSMT | OSMOTICA PHARMACEUTICALS PLC | $864,000 | +1.1% | 225,000 | 0.0% | 0.76% | +65.6% | |
| Sell | ORGANIGRAM HLDGS INC | $766,000 | -89.5% | 222,700 | -80.4% | 0.67% | -82.8% | |
| ALIM | ALIMERA SCIENCES INC | $234,000 | -36.4% | 413,300 | 0.0% | 0.21% | +4.0% | |
| APHA | APHRIA INC | $107,000 | -26.2% | 20,636 | 0.0% | 0.09% | +20.5% | |
| HEXO | HEXO CORP | $59,000 | -26.2% | 15,000 | 0.0% | 0.05% | +20.9% | |
| ATRS | Exit | ANTARES PHARMA INC | $0 | – | -380,524 | -100.0% | -0.67% | – |
| CNTTQ | Exit | CANNTRUST HLDGS INC | $0 | – | -843,909 | -100.0% | -2.28% | – |
| CGC | Exit | CANOPY GROWTH CORP | $0 | – | -1,241,201 | -100.0% | -26.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
| 4 | 2023-12-19 |
| 4 | 2023-12-12 |
| 4 | 2023-12-07 |
| 4 | 2023-12-06 |
| 4 | 2023-11-21 |
| 4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.